Your browser doesn't support javascript.
loading
Global Cancer Drug Development-A Report From the 2022 Accelerating Anticancer Agent Development and Validation Meeting.
Wilson, Brooke E; Sullivan, Richard; Peto, Richard; Abubakar, Bello; Booth, Christopher; Werutsky, Gustavo; Adams, Cary; Saint-Raymond, Agnes; Fleming, Thomas R; Lyerly, Kim; Gralow, Julie R.
  • Wilson BE; Division of Cancer Care and Epidemiology, Queen's Cancer Research Institute, Kingston, Canada.
  • Sullivan R; Department of Oncology, Queen's University, Kingston, Canada.
  • Peto R; Institute of Cancer Policy, King's College London, London, United Kingdom.
  • Abubakar B; Department of Oncology, Guy's & St Thomas' NHS Trust, London, United Kingdom.
  • Booth C; Department of Medical Statistics and Epidemiology, University of Oxford, Oxford, United Kingdom.
  • Werutsky G; Department of Radiotherapy and Oncology, National Hospital Abuja, Abuja, Nigeria.
  • Adams C; Division of Cancer Care and Epidemiology, Queen's Cancer Research Institute, Kingston, Canada.
  • Saint-Raymond A; Department of Oncology, Queen's University, Kingston, Canada.
  • Fleming TR; Department of Medical Oncology, Hospital São Lucas, Porto Alegre, Brazil.
  • Lyerly K; Union for International Cancer Control, Geneva, Switzerland.
  • Gralow JR; International Affairs Division, European Medicines Agency, Amsterdam, the Netherlands.
JCO Glob Oncol ; 9: e2300294, 2023 Sep.
Article en En | MEDLINE | ID: mdl-37944089
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias / Antineoplásicos Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias / Antineoplásicos Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article